A word of caution on using tumor biomarker reference change values to guide medical decisions and the need for alternatives.

van Rossum, Huub H; Meng, Qing H; Ramanathan, Lakshmi V; Holdenrieder, Stefan

van Rossum, Huub H; Meng, Qing H; Ramanathan, Lakshmi V; Holdenrieder, Stefan.

Afiliação

van Rossum HH; Department of Laboratory Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Meng QH; Department of Laboratory Medicine, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ramanathan LV; Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Holdenrieder S; Institute of Laboratory Medicine, Munich Biomarker Research Center, Deutsches Herzzentrum München, Technische Universität Munchen, Munich, Germany.

Clin Chem Lab Med ; 60(4): 553-555, 2022 03 28.

Article em En | MEDLINE | ID: mdl-34648697

Assuntos

Biomarcadores Tumorais; Medicina Baseada em Evidências; Humanos; Valores de Referência

Palavras-chave

evidence based-medicine; reference change value; tumor biomarker

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Medicina Baseada em Evidências Limite: Humans Idioma: En Revista: Clin Chem Lab Med Assunto da revista: QUIMICA CLINICA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google